Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-10057-7, published online 09 April 2022
The original version of this Article contained a repeated error in the Title, in the Results section under the subheading ‘Antigenic reactivity of synthetic peptides with COMIRNATY vaccine recipient sera’ and in the Methods section under the subheading ‘Serum samples from COMIRNATY vaccine recipients’ where
“COMINARTY”
now reads:
“COMIRNATY”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Andries, J., Viranaicken, W., Cordonin, C. et al. Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech). Sci Rep 12, 6498 (2022). https://doi.org/10.1038/s41598-022-10885-7
Published:
DOI: https://doi.org/10.1038/s41598-022-10885-7
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
